[Retracted] Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department
Table 3
Predictive value of the prognostic scores calculated for 28-day, 90-day, and 6-month survival.
Prognostic score
AUROC
Asymptotic sig
Cut-off point
Sensitivity (%)
Specificity (%)
PLV
NLV
28-day mortality
Child-Pugh score
0.680
<0.0001
14
77.30
52.00
1.61
0.44
MELD score
0.691
<0.0001
9
74.86
58.00
1.78
0.43
MELD-Na score
0.666
<0.0001
19.40
89.37
40.82
1.51
0.26
iMELD score
0.681
<0.0001
34.22
71.08
64.00
1.97
0.45
ALBI score
0.714
<0.0001
-1.168
73.17
64.00
2.03
0.42
90-day mortality
Child-Pugh score
0.663
<0.0001
8
62.96
62.82
1.69
0.59
MELD score
0.713
<0.0001
12
66.67
67.95
2.08
0.49
MELD-Na score
0.707
<0.0001
14.95
78.26
54.12
1.71
0.40
iMELD score
0.712
<0.0001
34.10
74.29
65.12
2.13
0.39
ALBI score
0.693
<0.0001
-0.997
85.86
62.82
2.31
0.23
6-month mortality
Child-Pugh score
0.679
<0.0001
8
64.76
63.95
1.80
0.55
MELD score
0.723
<0.0001
12
67.62
67.44
2.08
0.48
MELD-Na score
0.703
<0.0001
14.95
78.26
64.94
1.86
0.41
iMELD score
0.713
<0.0001
34.10
74.29
65.12
2.13
0.39
ALBI score
0.693
<0.0001
-1.188
79.15
54.65
1.71
0.41
MELD: model for end-stage liver disease; MELD-Na: MELD combined with serum sodium concentration; iMELD: integrated MELD; ALBI: albumin-bilirubin score; PLV: positive likelihood ratio; NLV: negative likelihood ratio.
